ArticleESMO open2021

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study.

J Tabernero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.